Wikidata

(Q61969377)

English

A Study of Oprozomib, Pomalidomide, and Dexamethasone in Subjects With Primary Refractory or Relapsed and Refractory Multiple Myeloma

clinical trial

In more languages

Statements

title
Phase 1b/3 Multicenter Study of Oprozomib, Pomalidomide, and Dexamethasone in Primary Refractory or Relapsed and Refractory Multiple Myeloma Subjects (English)
0 references
sponsor
Amgen
0 references
start time
November 2013
0 references
end time
30 April 2019
0 references
number of participants
33
0 references
research intervention
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
pomalidomide
0 references
thalidomide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61969377&oldid=2117411910"